M. Sabdia

Intratumoral T‐cell receptor repertoire is predictive of interim PET scan results in patients with diffuse large B‐cell lymphoma treated with rituximab/cyclophosphamide/doxorubicin/prednisolone/vincristine (R‐CHOP) chemoimmunotherapy

M. Gandhi, Zhixiu Li, J. Gunawardana, 2021, Clinical & translational immunology.

Neoantigens - the next frontier in precision immunotherapy for B-cell lymphoproliferative disorders.

A. Patch, M. Gandhi, M. Sabdia, 2022, Blood reviews.

Intratumoral T cells have a differential impact on FDG-PET parameters in follicular lymphoma.

M. Gandhi, J. Gunawardana, D. Sester, 2021, Blood advances.

LAG3: a novel immune checkpoint expressed by multiple lymphocyte subsets in diffuse large B-cell lymphoma.

A. Gill, M. Gandhi, K. Young, 2020, Blood advances.

Targeting Replication Stress Using CHK1 Inhibitor Promotes Innate and NKT Cell Immune Responses and Tumour Regression

N. Haass, B. Gabrielli, R. Dolcetti, 2021, Cancers.

EBV microRNA-BHRF1-2-5p targets the 3'UTR of immune checkpoint ligands PD-L1 and PD-L2.

Rachael A. West, M. Gandhi, J. Gunawardana, 2019, Blood.

Circulating cell-free miR-494 and miR-21 are disease response biomarkers associated with interim-positron emission tomography response in patients with diffuse large B-cell lymphoma

G. Rice, M. Gandhi, A. Cristino, 2018, Oncotarget.

EBV-tissue positive primary CNS lymphoma occurring after immunosuppression is a distinct immunobiological entity.

L. Rimsza, G. Bhagat, J. L. Fink, 2020, Blood.

Cathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular Lymphoma.

W. Klapper, R. Kridel, C. Steidl, 2020, Cell reports.

Successful treatment of Epstein–Barr virus–associated primary central nervous system lymphoma due to post‐transplantation lymphoproliferative disorder, with ibrutinib and third‐party Epstein–Barr virus–specific T cells

M. Gandhi, J. Gunawardana, S. Hennig, 2021, American Journal of Transplantation.

Genetic aberrations of NLRC5 are associated with downregulated MHC‐I antigen presentation and impaired T‐cell immunity in follicular lymphoma

M. Gandhi, J. Gunawardana, V. Murigneux, 2020, EJHaem.

The IRE1α-endonuclease regulates PD-1 expression through a novel XBP1/miRNA-34a axis within Natural Killer cells

M. Gandhi, J. Gunawardana, A. Cristino, 2023, bioRxiv.

Resolution of Melanoma to Programmed Death-1 Blockade but Simultaneous Rapid Progression of Concomitant Chronic Lymphocytic Leukemia

M. Gandhi, A. Ewing, D. Gill, 2022, Acta Haematologica.

Successful treatment of EBV-associated Primary CNS Lymphoma due to PTLD, with Ibrutinib and 3rd Party EBV-specific T cells.

J. Gunawardana, J. Tobin, K. Bednarska, 2021, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.